The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
Department of Medicine, Charing Cross and Westminster Medical School, London, England.
S P
SP
Davies
E A
EA
Brown
D F
DF
Woodrow
M E
ME
Phillips
P E
PE
Gower
A D
AD
Mee
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004351:Drug Resistance; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D013256:Steroids; D008775:Methylprednisolone